NasdaqGM - Nasdaq Real Time Price USD
Larimar Therapeutics, Inc. (LRMR)
1.8750
-0.2050
(-9.86%)
At close: May 13 at 4:00:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-86,889
-70,760
-33,459
-27,569
-42,105
Investing Cash Flow
-2,575
-85,387
33,353
-90,960
24,169
Financing Cash Flow
-268
161,883
30
75,257
19,885
End Cash Position
21,732
33,824
28,088
28,164
71,436
Capital Expenditure
-109
-515
-164
-100
-333
Issuance of Capital Stock
-345
161,806
0
75,257
19,885
Free Cash Flow
-87,453
-71,275
-33,623
-27,669
-42,438
12/31/2021 - 6/19/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LXEO Lexeo Therapeutics, Inc.
2.8300
+7.60%
INZY Inozyme Pharma, Inc.
1.0900
-7.63%
SLDB Solid Biosciences Inc.
2.7900
-3.79%
NKTR Nektar Therapeutics
0.7100
-0.67%
VSTM Verastem, Inc.
7.46
+2.33%
ABEO Abeona Therapeutics Inc.
5.63
+0.54%
CRVS Corvus Pharmaceuticals, Inc.
3.8900
-4.07%
SLNO Soleno Therapeutics, Inc.
74.44
-2.95%
OLMA Olema Pharmaceuticals, Inc.
4.6800
-1.68%
SGMT Sagimet Biosciences Inc.
3.1800
-3.93%